Pharmaceutical Quality and Counterfeiting
Pharmaceutical Quality and Counterfeiting is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 6.8k research works in it since 1953. 23.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the global impact of counterfeit drugs, particularly in the context of antimalarial and other essential medicines. It addresses the public health risks, pharmaceutical counterfeiting, medicine adulteration, and the development of detection technologies to combat the proliferation of counterfeit drugs. The cluster also discusses the challenges associated with online pharmacies and emphasizes the importance of ensuring drug quality for patient safety.
- Counterfeit Drugs
- Substandard Medicines
- Antimalarial Drugs
- Drug Quality
- Public Health Risks
- Pharmaceutical Counterfeiting
- Medicine Adulteration
- Detection Technologies
- Online Pharmacies
- Patient Safety
- Research works
- 6.8k fractional, since 1953
- In the world top 10%
- 1.6k per year above
- Top-10% rate
- 23.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +39% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pharmaceutical Quality and Counterfeiting research?
By volume, India and the United States publish the most (272 and 234 works in 2022–2025).
By volume, 2022–2025
- 1 India 272 works
- 2 United States 234 works
- 3 China 107 works
- 4 United Kingdom 89 works
- 5 Nigeria 69 works
- 6 Ethiopia 59 works
- 7 Indonesia 54 works
- 8 Saudi Arabia 42 works
- 9 France 39 works
- 10 Pakistan 38 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pharmaceutical Quality and Counterfeiting research?
By volume in 2022–2025, University of Gondar publishes the most Pharmaceutical Quality and Counterfeiting research, followed by Hindu College of Pharmacy and King Saud University.
By volume, 2022–2025
- 1 University of GondarEthiopia 11 works
- 2 Hindu College of PharmacyIndia 10 works
- 3 King Saud UniversitySaudi Arabia 10 works
- 4 Addis Ababa UniversityEthiopia 9 works
- 5 University of North Carolina at Chapel HillUnited States 9 works
- 6 National Institute for Pharmaceutical Research and DevelopmentNigeria 7 works
- 7 Jimma UniversityEthiopia 6 works
- 8 Manipal Academy of Higher EducationIndia 6 works
- 9 Makerere UniversityUganda 6 works
- 10 Muhimbili University of Health and Allied SciencesTanzania 6 works
Who are the leading researchers in Pharmaceutical Quality and Counterfeiting?
The most-cited researchers publishing on Pharmaceutical Quality and Counterfeiting include Yaser Mohammed Al‐Worafi.
- 1 Yaser Mohammed Al‐Worafi United Arab Emirates 1.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pharmaceutical Quality and Counterfeiting research done?
The largest centres of Pharmaceutical Quality and Counterfeiting research in 2022–2025 are London (United Kingdom), New Delhi (India), Riyadh (Saudi Arabia) and Moscow (Russia).
Where is the best place to study Pharmaceutical Quality and Counterfeiting?
Among universities, judged by research, Addis Ababa University, University of Gondar and King Saud University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Addis Ababa UniversityEthiopia | 80.8 | 32.7% | 21.9× | 9 | +798.3% |
| 2 | University of GondarEthiopia | 75.3 | 25.4% | 40.2× | 11 | — |
| 3 | King Saud UniversitySaudi Arabia | 54.9 | 29.3% | 5.8× | 10 | +52.3% |
| 4 | Hindu College of PharmacyIndia | 47.3 | 0.0% | 54.4× | 10 | — |
| 5 | University of North Carolina at Chapel HillUnited States | 27.5 | 13.6% | 2.9× | 9 | +249.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pharmaceutical Quality and Counterfeiting research growing?
Output in 2018–2022 was 39% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Pharmaceutical Quality and Counterfeiting.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.